Indications
Aprima is used to treat adults with active psoriatic arthritis, and adults with moderate to severe plaque psoriasis who are suitable candidates for phototherapy or systemic therapy.
⚠️ Always consult a registered physician before taking any medicine.
Pharmacology
Apremilast is a novel, orally available small molecule that inhibits type 4 cyclic nucleotide phosphodiesterase (PDE-4). PDE-4 is a cyclic adenosine monophosphate (cAMP) specific phosphodiesterase found mainly in inflammatory cells. By inhibiting PDE-4, apremilast raises intracellular levels of cAMP, which in turn suppresses the production of several proinflammatory mediators, including PDE-4, TNF-alpha, interleukin-2 (IL-2), interferon-gamma, leukotrienes, and nitric oxide synthase. Because it acts on a central component of the inflammatory signaling cascade rather than a single inflammatory marker, PDE-4 inhibition may help restore the natural balance between pro-inflammatory and anti-inflammatory signaling.
Pregnancy & Breastfeeding
Pregnancy Category C. It is not known whether Apremilast or its breakdown products pass into human breast milk, though it has been found in the milk of nursing mice. As a precaution, it should be used carefully in breastfeeding mothers.
⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
Dosage Reference
⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.
Side Effects & Interactions
Side Effects
No side-effect data recorded yet.